Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ma, Sills"'
Autor:
Mh, Chin, Cl, Cioffi, Garay M, Rf, Neale, Ss, Shetty, DelGrande D, Mugrage B, Ma, Sills, Kenneth Lipson
Publikováno v:
Europe PubMed Central
CGS 27830 [meso-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(3- nitrophenyl)-3-pyridine carboxylic acid anhydride] is a nonpeptidic, insurmountable, endothelin (ET) receptor antagonist with approximately 10- to 20-fold selectivity for ETA receptors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7b8d52b5a4d0915627493c0568b1ad9e
http://europepmc.org/abstract/med/8558459
http://europepmc.org/abstract/med/8558459
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 2005 Sep; Vol. 10 (6), pp. 581-9. Date of Electronic Publication: 2005 Aug 15.
Autor:
Wu X; Exelixis, South San Francisco, CA 94083-0511, USA. swu@exelixis.com, Glickman JF, Bowen BR, Sills MA
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 2003 Aug; Vol. 8 (4), pp. 381-92.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2001; Vol. 484, pp. 77-87.
Autor:
Wu JJ; Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation, Summit, NJ 07901, USA. jinzi.wu@phrma.novartis.com, Yarwood DR, Sills MA, Chaudhuri B, Muller L, Zurini M, Sills MA
Publikováno v:
Combinatorial chemistry & high throughput screening [Comb Chem High Throughput Screen] 2000 Feb; Vol. 3 (1), pp. 27-36.
Autor:
Wu JJ; Immunex Corporation, Seattle, WA 98101, USA. jinziwu@yahoo.com, Yarwood DR, Pham Q, Sills MA
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 2000 Feb; Vol. 5 (1), pp. 23-30.
Autor:
Abriola L; Novartis Institute of Biomedical Research, Summit, NJ., Chin M, Fuerst P, Schweitzer R, Sills MA
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 1999; Vol. 4 (3), pp. 121-127.